C3BS enrols 240th patient in CHART-1 European …

C3BS enrols 240th patient in CHART-1 European trial of C-Cure for treatment of congestive heart failure | Biotech License

Select CategoryBiotech Articles (22)Biotech FAQ (222)Biotech News (465)Biotech Patents (47)Biotech Videos (37)Pharmaceutical News (124)

Link: 

C3BS enrols 240th patient in CHART-1 European …

See which stocks are being affected by Social Media

 […]

Integrity Research» Blog Archive » iSentium Launches Sentiment …

Last week, social media analytics vendor, iSentium, announced the launch of its completely revamped iSENSE application on the Bloomberg terminal to enable investment professionals to access real-time market sentiment from Twitter.New iSense ReleaseIn October 2013, Bloomberg initially released the iSense application on its market data terminal developed by the social media analytics company, iSentium. The iSense app generated sentiment signals […]